Shandong Weigao Group Medical Polymer Co (HKSE:01066) Accounts Payable & Accrued Expense : HK$5,877 Mil (As of Jun. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Accounts Payable & Accrued Expense?

Shandong Weigao Group Medical Polymer Co's quarterly accounts payable & accrued expense declined from Jun. 2022 (HK$5,362 Mil) to Dec. 2022 (HK$5,148 Mil) but then increased from Dec. 2022 (HK$5,148 Mil) to Jun. 2023 (HK$5,877 Mil).

Shandong Weigao Group Medical Polymer Co's annual accounts payable & accrued expense increased from Dec. 2020 (HK$4,673 Mil) to Dec. 2021 (HK$5,094 Mil) and increased from Dec. 2021 (HK$5,094 Mil) to Dec. 2022 (HK$5,148 Mil).

Shandong Weigao Group Medical Polymer Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Accounts Payable & Accrued Expense Chart

Shandong Weigao Group Medical Polymer Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3,773.33

4,672.51

5,094.13

5,147.85

4,987.36

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5,094.13	5,362.31	5,147.85	5,876.86	4,987.36

Shandong Weigao Group Medical Polymer Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

SHWGY:USA SHWGF:USA UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Headlines

No Headlines